This video is for educational purposes. In September 2026, President John Dramani Mahama publicly explained why his government rejected the proposed agreement with the United States. The government raised three major concerns: Medical data privacy: The agreement raised concerns about sharing sensitive medical records and health information with US entities, potentially without adequate safeguards. Additional financial contributions: Ghana was expected to contribute some of its own money towards the healthcare programme, alongside the US funding. Ghana's authority over medicines: The government objected to provisions concerning the US Food and Drug Administration's powers over medical products brought into Ghana, which Mahama considered an affront to Ghana's sovereignty. The proposed funding was intended to support Ghana's healthcare system and the fight against diseases such as: HIV/AIDS Malaria Tuberculosis Polio The agreement was part of the Trump administration's new global health funding strategy. It would have provided approximately $109 million in US funding over five years, with additional contributions expected from Ghana. As of October 10, 2026, President John Dramani Mahama has disclosed that the United States is seeking to revise its rejected $109 million health funding agreement with Ghana. According to a report published today by MyJoyOnline, the US wants to amend or remove some of the clauses that caused Ghana's Cabinet to reject the original agreement. There is an interesting development. The US and Zambia signed a revised health financing agreement on October 8, 2026, after removing controversial clauses concerning patient data and medical specimens. This suggests that the US is willing to negotiate changes to its health agreements with African countries. My conclusion: Ghana's rejection did not necessarily end negotiations. The US is now seeking changes, but we need confirmation of the final terms to know whether Ghana will receive the funding. #ghana #fyp #USAID #GhanaHealth - @diaries_of_hope.fdn